Bcl-2 overexpression has been implicated in several forms of cancer cells that rely heavily on Bcl-2 for their survival, such as chronic lymphocytic leukemia (CLL), certain types of lymphomas, and AML [99,100,101,102]. This evidence concerns the gene BCL2 and acute myeloid leukemia.